Modis Therapeutics Overview

  • Founded
  • 2016
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $246M
Latest Deal Amount

Modis Therapeutics General Information

Description

Operator of a biopharmaceutical company intended to develop disease-modifying therapies for rare genetic diseases with a high unmet medical need. The company's therapeutics are under clinical development and focuses on treating thymidine kinase 2 deficiency (TK2d), an inherited mitochondrial disease, enabling medical professionals to improve nucleotide balance, increases mtDNA copy number, cell function and prolongs life.

Contact Information

Website
www.modistx.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Parent Company
Primary Office
  • 409 13th Street
  • Suite 700
  • Oakland, CA 94612
  • United States
+1 (510) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Modis Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 09-Sep-2019 $246M 0000 00000 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Oct-2018 0000 0000 0000 Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Modis Therapeutics’s complete valuation and funding history, request access »

Modis Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A2 0,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series A1 00,000,000 00.000000 00.00 00 00 00 00 00.000
To view Modis Therapeutics’s complete cap table history, request access »

Modis Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a biopharmaceutical company intended to develop disease-modifying therapies for rare genetic diseases with a
Biotechnology
Oakland, CA
0000
0000 0000-00-00
000000&0 0000

0000 000

pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit
0000000000000
Santa Monica, CA
000 As of 0000
00000
000 0000-00-00
000000&0 00000

00000000

elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, q
0000000000000
San Diego, CA
0 As of 0000
000.00
00.00 0000-00-00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Modis Therapeutics Competitors (40)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Kite Pharma Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
000000000 00000000 Venture Capital-Backed San Diego, CA 0 000.00 000000000 000.00
0000000 Venture Capital-Backed Cambridge, MA 000 00000000000 000
00000000 000000000 Venture Capital-Backed Wayne, PA 000.00 00000000000 000.00
0000 (000000000000 Venture Capital-Backed Jerusalem, Israel 00 000.00 00000000000 000.00
You’re viewing 5 of 40 competitors. Get the full list »

Modis Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Joshua Grass President, Board Member & Chief Executive Officer
Peter Barber Co-Founder, Board Member & Chief Business Officer
Daniel DiPietro Co-Founder & Senior Vice President, New Science Opportunities
Joanne Quan MD Chief Medical Officer
You’re viewing 4 of 5 executive team members. Get the full list »

Modis Therapeutics Board Members (5)

Name Representing Role Since
Ben Auspitz F-Prime Capital Chairman 000 0000
Joshua Grass Modis Therapeutics President, Board Member & Chief Executive Officer 000 0000
Matthew Patterson OrbiMed Board Member 000 0000
Peter Barber Modis Therapeutics Co-Founder, Board Member & Chief Business Officer 000 0000
Rishi Gupta JD OrbiMed Board Member 000 0000
To view Modis Therapeutics’s complete board members history, request access »

Modis Therapeutics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aceras BioMedical Other Minority 000 0000 000000 0
Downstate's Biotechnology Incubator Accelerator/Incubator 000 0000 000000 0
F-Prime Capital Venture Capital Minority 000 0000 000000 0
OrbiMed PE/Buyout Minority 000 0000 000000 0
Osage University Partners Venture Capital Minority 000 0000 000000 0
To view Modis Therapeutics’s complete investors history, request access »